Investigating how ergosterol peroxide can selectively inhibit aggressive breast cancer
Validating the mode of action of ergosterol peroxide as a selective breast cancer inhibitor
This study is looking at how a natural compound from fungi, called ergosterol peroxide, can help fight triple-negative breast cancer by killing cancer cells without harming normal cells, with the hope of creating a new treatment option for patients facing this tough type of cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Universidad Central Del Caribe NIH-funded |
| Lab location | 1 site (Bayamon, United States) |
| Project ID | NIH-11060936 on NIH RePORTER |
What this research studies
This research focuses on understanding how ergosterol peroxide, a natural compound found in fungi, can effectively target and inhibit triple-negative breast cancer (TNBC) cells while sparing normal cells. The study aims to identify the specific mechanisms through which ergosterol peroxide induces cell death in TNBC, which is known for its aggressive nature and poor prognosis. By exploring the compound's effects on tumor growth and its ability to induce oxidative stress and apoptosis in cancer cells, the research seeks to develop a new targeted therapy for patients suffering from this challenging cancer subtype.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with triple-negative breast cancer, particularly younger women under 40 years old.
Not a fit: Patients with other types of breast cancer or those who do not have a diagnosis of breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a new, effective treatment option for patients with triple-negative breast cancer, potentially improving survival rates and reducing treatment-related side effects.
How similar studies have performed: Previous research has shown promise in using natural compounds like ergosterol peroxide for cancer treatment, indicating potential for success in this novel approach.
Where this research is happening
Bayamon, United States
- Universidad Central Del Caribe — Bayamon, United States (Active)
Researchers
- Principal investigator: Martinez, Michelle M — Universidad Central Del Caribe
- Study coordinator: Martinez, Michelle M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.